{"id":"https://openalex.org/W2007069751","doi":"https://doi.org/10.1038/bjc.1993.352","title":"A phase I study of intravenous bryostatin 1 in patients with advanced cancer","display_name":"A phase I study of intravenous bryostatin 1 in patients with advanced cancer","alternate_titles":[],"publication_year":1993,"publication_date":"1993-08-01","ids":{"openalex":"https://openalex.org/W2007069751","doi":"https://doi.org/10.1038/bjc.1993.352","mag":"2007069751","pmid":"https://pubmed.ncbi.nlm.nih.gov/8347500","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1968558"},"language":"en","primary_location":{"id":"doi:10.1038/bjc.1993.352","doi":"https://doi.org/10.1038/bjc.1993.352","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.1993.352","pdf_url":"https://www.nature.com/articles/bjc1993352.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2007069751"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nature.com/articles/bjc1993352.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075322358","display_name":"J Prendiville","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Prendiville","raw_affiliation_strings":["CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210129527","https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111377544","display_name":"Derek Crowther","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Crowther","raw_affiliation_strings":["CRC Departments of 'Medical Oncology , 2Experimental Chemotherapy , 3Experimental Haematology and 4lmmunology , Paterson Institute and Christie Hospital NHS Trust , Manchester , UK,","Christie Hospital NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Departments of 'Medical Oncology , 2Experimental Chemotherapy , 3Experimental Haematology and 4lmmunology , Paterson Institute and Christie Hospital NHS Trust , Manchester , UK,","institution_ids":[]},{"raw_affiliation_string":"Christie Hospital NHS Foundation Trust","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110052001","display_name":"N. Thatcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N Thatcher","raw_affiliation_strings":["CRC Departments of 'Medical Oncology , 2Experimental Chemotherapy , 3Experimental Haematology and 4lmmunology , Paterson Institute and Christie Hospital NHS Trust , Manchester , UK,","Christie Hospital NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Departments of 'Medical Oncology , 2Experimental Chemotherapy , 3Experimental Haematology and 4lmmunology , Paterson Institute and Christie Hospital NHS Trust , Manchester , UK,","institution_ids":[]},{"raw_affiliation_string":"Christie Hospital NHS Foundation Trust","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004384935","display_name":"Penella J. Woll","orcid":"https://orcid.org/0000-0002-1118-0831","observed_orcids":["https://orcid.org/0000-0002-1118-0831"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"PJ Woll","raw_affiliation_strings":["CRC Departments of 'Medical Oncology , 2Experimental Chemotherapy , 3Experimental Haematology and 4lmmunology , Paterson Institute and Christie Hospital NHS Trust , Manchester , UK,","Christie Hospital NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Departments of 'Medical Oncology , 2Experimental Chemotherapy , 3Experimental Haematology and 4lmmunology , Paterson Institute and Christie Hospital NHS Trust , Manchester , UK,","institution_ids":[]},{"raw_affiliation_string":"Christie Hospital NHS Foundation Trust","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111815912","display_name":"Brian W. Fox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"BW Fox","raw_affiliation_strings":["CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","Christie Hospital NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210129527","https://openalex.org/I4210131968"]},{"raw_affiliation_string":"Christie Hospital NHS Foundation Trust","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103585228","display_name":"Alan T. McGown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A McGown","raw_affiliation_strings":["CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","Christie Hospital NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210129527","https://openalex.org/I4210131968"]},{"raw_affiliation_string":"Christie Hospital NHS Foundation Trust","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109101316","display_name":"Nydia G. Testa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N Testa","raw_affiliation_strings":["CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","Christie Hospital NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210129527","https://openalex.org/I4210131968"]},{"raw_affiliation_string":"Christie Hospital NHS Foundation Trust","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082997520","display_name":"Peter L. Stern","orcid":"https://orcid.org/0000-0002-0604-9097","observed_orcids":["https://orcid.org/0000-0002-0604-9097"]},"institutions":[{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Stern","raw_affiliation_strings":["CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","Christie Hospital NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210129527","https://openalex.org/I4210131968"]},{"raw_affiliation_string":"Christie Hospital NHS Foundation Trust","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025587605","display_name":"R. H. McDermott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R McDermott","raw_affiliation_strings":["CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","Christie Hospital NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Department of Medical Oncology, Paterson Institute and Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210129527","https://openalex.org/I4210131968"]},{"raw_affiliation_string":"Christie Hospital NHS Foundation Trust","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113487304","display_name":"M Potter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259061","display_name":"Northern Care Alliance NHS Foundation Trust","ror":"https://ror.org/01nqeyn25","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4405259061"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Potter","raw_affiliation_strings":["CRC Departments of 'Medical Oncology , 2Experimental Chemotherapy , 3Experimental Haematology and 4lmmunology , Paterson Institute and Christie Hospital NHS Trust , Manchester , UK,","Northern Care Alliance NHS Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Departments of 'Medical Oncology , 2Experimental Chemotherapy , 3Experimental Haematology and 4lmmunology , Paterson Institute and Christie Hospital NHS Trust , Manchester , UK,","institution_ids":[]},{"raw_affiliation_string":"Northern Care Alliance NHS Group","institution_ids":["https://openalex.org/I4405259061"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111896386","display_name":"GR Pettit","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"GR Pettit","raw_affiliation_strings":["Biodesign Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biodesign Institute","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":12.3599,"has_fulltext":true,"cited_by_count":155,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99626343,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"68","issue":"2","first_page":"418","last_page":"424"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11340","display_name":"Marine Sponges and Natural Products","score":0.19339999556541443,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11340","display_name":"Marine Sponges and Natural Products","score":0.19339999556541443,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.06069999933242798,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.05480000004172325,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/marine-natural-products","display_name":"marine natural products","score":0.593999981880188},{"id":"https://openalex.org/keywords/bugula-neritina","display_name":"Bugula neritina","score":0.9020000100135803},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.902999997138977},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8320000171661377},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8619999885559082},{"id":"https://openalex.org/keywords/myalgia","display_name":"myalgia","score":0.9660000205039978},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7059999704360962},{"id":"https://openalex.org/keywords/neutrophil-superoxide-production","display_name":"neutrophil superoxide production","score":0.8080000281333923},{"id":"https://openalex.org/keywords/nk-cell-cytotoxicity","display_name":"NK cell cytotoxicity","score":0.8309999704360962},{"id":"https://openalex.org/keywords/antitumour-activity","display_name":"antitumour activity","score":0.8289999961853027},{"id":"https://openalex.org/keywords/hematopoietic-progenitor-cells","display_name":"hematopoietic progenitor cells","score":0.7020000219345093},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C2910806222","wikidata":"https://www.wikidata.org/wiki/Q4981136","display_name":"Bryostatin 1","level":4,"score":0.8085545301437378},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8063368201255798},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5929067134857178},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.42716801166534424},{"id":"https://openalex.org/C51296783","wikidata":"https://www.wikidata.org/wiki/Q1645498","display_name":"Microgram","level":3,"score":0.41633307933807373},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4154830574989319},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.4129582643508911},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40915554761886597},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.39038413763046265},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12675949931144714},{"id":"https://openalex.org/C88045685","wikidata":"https://www.wikidata.org/wiki/Q174576","display_name":"Activator (genetics)","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003114","descriptor_name":"Colony-Forming Units Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D007962","descriptor_name":"Leukocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007962","descriptor_name":"Leukocytes","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D008654","descriptor_name":"Mesothelioma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010587","descriptor_name":"Phagocytosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018942","descriptor_name":"Macrolides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054713","descriptor_name":"Bryostatins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1038/bjc.1993.352","doi":"https://doi.org/10.1038/bjc.1993.352","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.1993.352","pdf_url":"https://www.nature.com/articles/bjc1993352.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:1503811","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1968558","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:1968558","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1968558/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:8347500","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8347500","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial"},{"id":"pmh:oai:eprints.whiterose.ac.uk:83686","doi":null,"is_oa":false,"landing_page_url":"http://eprints.whiterose.ac.uk/83686/1/A%20phase%20I%20study%20of%20intravenous%20bryostatin%201%20in%20patients%20with%20advanced%20cancer..pdf","pdf_url":"http://eprints.whiterose.ac.uk/83686/1/A%20phase%20I%20study%20of%20intravenous%20bryostatin%201%20in%20patients%20with%20advanced%20cancer..pdf","source":{"id":"https://openalex.org/S4306400854","display_name":"White Rose Research Online (University of Leeds, The University of Sheffield, University of York)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800616092","host_organization_name":"White Rose University Consortium","host_organization_lineage":["https://openalex.org/I2800616092"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1038/bjc.1993.352","doi":"https://doi.org/10.1038/bjc.1993.352","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.1993.352","pdf_url":"https://www.nature.com/articles/bjc1993352.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2007069751.pdf","grobid_xml":"https://content.openalex.org/works/W2007069751.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W95673823","https://openalex.org/W272219667","https://openalex.org/W1502051558","https://openalex.org/W1546234190","https://openalex.org/W1560197506","https://openalex.org/W1587206101","https://openalex.org/W1588356042","https://openalex.org/W1594758412","https://openalex.org/W1605863240","https://openalex.org/W1937458778","https://openalex.org/W1968526337","https://openalex.org/W1973625300","https://openalex.org/W1989859193","https://openalex.org/W2004592968","https://openalex.org/W2032336406","https://openalex.org/W2038905259","https://openalex.org/W2049179050","https://openalex.org/W2052027104","https://openalex.org/W2060969354","https://openalex.org/W2064541977","https://openalex.org/W2069723308","https://openalex.org/W2094546664","https://openalex.org/W2136059623","https://openalex.org/W2136536126","https://openalex.org/W2138727941","https://openalex.org/W2139160552","https://openalex.org/W2144133812","https://openalex.org/W2159084718","https://openalex.org/W2159348936","https://openalex.org/W2166030036","https://openalex.org/W2412242604","https://openalex.org/W2414680744","https://openalex.org/W2415372781","https://openalex.org/W2416241732","https://openalex.org/W3005434895","https://openalex.org/W4229505346"],"related_works":["https://openalex.org/W2116403966","https://openalex.org/W2052659638","https://openalex.org/W2140879800","https://openalex.org/W2011926633","https://openalex.org/W2161204659","https://openalex.org/W2275165869","https://openalex.org/W1582968384","https://openalex.org/W222191070","https://openalex.org/W2104242553","https://openalex.org/W1937458778"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2007069751","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
